News

We are pleased to announce the inclusion of the first two patients in the TACTIC study. The first patient was enrolled by Prof Alaide Chieffo from Ospedale San Raffaele, Milan, followed by a second inclusion by Dr Mario Iannaccone from San Giovanni Bosco Hospital, Turin. TACTIC study is an...

The entire CERC team extends our sincere congratulations to Prof. Roxana Mehran on her appointment as President of the American College of Cardiology for 2026. Prof. Mehran’s leadership, vision, and enduring contributions to cardiovascular medicine and clinical research continue to shape the field...

CERC continues to expand its footprint within the global cardiovascular community at ACC Congress 2026 in New Orleans As a physician-driven, full-service CRO, CERC continues to support the design and execution of innovative clinical trials that address key unmet needs in cardiovascular medicine....

We are pleased to announce the successful treatment of the first patient in the FIH IPERF-01 first-in-human study. This clinical investigation evaluates the IPERF femoral arterial cannula, an innovative device featuring a novel dual-flow technology designed to enable simultaneous perfusion of the...

CYCLOPES Trial Design and Rationale Published CERC is pleased to announce the publication of the design and rationale of the CYCLOPES Trial. The article details the scientific background, objectives, and study design of CYCLOPES, study, providing transparency on the trial’s methodological approach...

CERC is proud to share that TARGET FIRST and SELUTION DeNovo , both conducted with CERC, have been selected among the Top 10 studies in interventional cardiology in 2025 by the European Heart Journal. CERC is proud to share that TARGET FIRST and SELUTION DeNovo, both conducted with CERC, have been...

We are proud to share that the ALL WOMEN study has successfully reached its enrollment goal, and patient inclusion is now completed. Thank you to everyone involved for your strong commitment and teamwork. The next focus is data completion for primary endpoint communications. Learn more about the ALL...

Several CERC members attended the High Tech Cardio Congress in Marseille, a leading international event dedicated to innovation in cardiovascular medicine. CERC members Antoinette Neylon, Thomas Cuisset, Philippe Garot, and Didier Tchétché were present at the congress and actively participated in...

CERC is proud to support the publication of clinical trial results, working closely with investigators and sponsors to ensure high-quality scientific output and visibility in leading peer-reviewed journals. In 2025, CERC-supported studies resulted in 15 publications in major international journals...

The ABILITY Diabetes Global study has now been officially published in The Lancet, marking an important milestone for this large international clinical trial. The study was conducted under the scientific leadership of Mount Sinai and sponsored by Concept Medical, with the active involvement of a...